Predict your next investment

StartUp Health company logo
Venture Capital
BUSINESS PRODUCTS & SERVICES | Consulting & Outsourcing / Management & Strategy Consulting
startuphealth.com

See what CB Insights has to offer

Investments

129

Portfolio Exits

11

Funds

2

Partners & Customers

10

About StartUp Health

StartUp Health is a new model for helping companies succeed in the health sector. Part community, part Academy, it provides health and wellness entrepreneurs with a structured curriculum designed to help navigate the unique challenges of building a sustainable growth business.

StartUp Health Headquarter Location

85 Broad Street 29th Floor

New York, New York, 10004,

United States

646-736-7401

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing StartUp Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find StartUp Health in 1 Expert Collection, including Conference Exhibitors.

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

StartUp Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

StartUp Health Rank

Latest StartUp Health News

StartUp Health takes a multidisciplinary approach to fight type 1 diabetes

Jul 4, 2022

July 4, 2022 David Weingard, chief impact officer of T1D Moonshot and founder of Cecelia Health, tells us how T1D Moonshot aims to break silos and advance type 1 diabetes prevention and treatment options by utilising numerous partners’ expertise. In the US alone, 37.3 million Americans live with diabetes, with 1.6 million having type 1 diabetes (T1D). Still, a scarcity of T1D treatments exists. T1D Moonshot aims to change that by bringing knowledgeable partners together from various sectors of the healthcare community to explore innovative ways to prevent and treat T1D. “Moonshots” within StartUp Health are large vision-based initiatives, similar to JFK’s dream of landing a person on the moon and bringing them back safely, Weingard says. They are projects with bold goals around cancer and other diseases that StartUp Health portfolio companies are organised around. “StartUp Health has 12 moonshots right now, and in working with the StartUp Health leadership, we realised that type 1 diabetes needs its own moonshot and dedicated focus,” Weingard states. “It’s an incredibly challenging and devastating disease affecting the lives of millions of people worldwide. It really needs a community of transformer companies to help make an impact.” With the help of companies, such as Eli Lilly, Diabetes Research Institute, Yale University, and the Helmsley Charitable Trust, along with other nonprofit organisations, investors, experts and entrepreneurs, T1D Moonshot aims to develop and accelerate patient access to T1D prevention and treatment options globally. The impact board T1D Moonshot’s “impact board” conjoins representatives from the world of investment, business, academia and foundations, aiming to accelerate innovation and improve efficiency in the overall T1D treatment development and distribution process. “What the impact board does is help support the vision and ensure we’re going in the right direction. For example, as we were forming the impact board, we realised and got feedback that we wanted to ensure that the Moonshot is accessible to all and addresses all socioeconomic groups and ethnicities. So, we thought hard about who to bring on,” Weingard says. The impact board comprises thought leaders such as Michael Mason of Eli Lilly, David Panzirer of the Helmsley Charitable Trust , and Sarah Oltmans of Robin Hood. “Sarah Oltmans is the chief of grant strategy at Robin Hood, who adds her experience working in Africa and elsewhere to the impact board and makes sure that anything we do in preventing, managing and curing T1D is accessible to all,” Weingard says. Additionally, with Eli Lilly’s Mason as a board member, pharma’s knowledge and resources are supplied to the cause, which can be invaluable. “Michael Mason is leading a $12 billion a year franchise for Lilly, from molecules to devices. He knows what’s missing in the T1D space. Also, there may be areas of innovation that Lilly is not going to invest in for whatever reason, and he’ll bring that knowledge to the discussion,” Weingard says. Mason can share where he sees a need among specific populations for better access to T1D remedies globally or which companies can affect T1D Moonshot’s cause. “What’s really cool is as you drill down on the impact board members, you see nonprofits who have never worked together before. So, we’re breaking down the silos,” Weingard says. “You have the largest nonprofit, the Juvenile Diabetes Research Foundation, their venture philanthropy fund, and Shaun Dougherty, their chairman, on the impact board. At the same time, we have Sean Kramer from the Diabetes Research Institute, the other nonprofit for T1D. So, the collaboration is exceptional.” The impact board meets formally during a quarterly meeting and informally in between. These are only a few examples of the resources the organisation plans to utilise to ensure the research and development process runs smoothly and improve patient access to materialised T1D Moonshot solutions. Call to action Alongside the established alliances within T1D Moonshot, a community of investors has joined the group. Together, they’re calling on innovators striving to make a change in the T1D space to join their cause. The Moonshot’s investors are ready and able to fund projects deployed by younger companies that may not have the access and resources to scale their innovation. “It’s not only about the capital access. It’s about bringing these innovative companies into the StartUp Health community, nurturing them, teaching them, guiding them and making connections for them,” Weingard states. “This is really an unbelievable opportunity for those entrepreneurs – they may be a doctor or a scientist – who don’t know much about the business world. They can apply and be part of the Moonshot, and we can help accelerate them to be successful.” To provide a clear picture of T1D Moonshot’s perspective, the impact board created a scorecard, which is public, defining the blueprint needed to make an impact in T1D. Weingard says if a company or individual is in the transformative part of the process, trying to make a real change, StartUp Health will want them in its community. “This blueprint is something we worked on for the last six to eight months to really assess the whole industry and the science. We want to be prescriptive. There are people who want to make an impact but don’t know what to do. Well, this is guidance for them,” Weingard states. “Now, all those places with R&D will have a place to become commercially enabled and be part of the commercial ecosystem. Even if we magically find a cure, that will require a whole army of companies to deliver it effectively – to screen, prevent, and manage.” The initiative is open to the global community, and capital will be deployed worldwide. Anyone can apply to join the team no matter where they reside. Weingard says the goal is for everyone to benefit from this cause. “We’re on the same mission. People are people. So, let’s help everyone, and let’s do it to ensure we give everyone access,” Weingard states. About the interviewee David Weingard is the founder of Cecelia Health (formerly Fit4D), a company that connects people with diabetes with a certified diabetes clinician. He’s a T1D advocate, and for his work he was recently named the Dare to Dream Honoree by the Diabetes Research Institute Foundation. Weingard has Type 1 diabetes himself yet has been able to manage the disease while becoming an ironman triathlon athlete. About the author Jessica Hagen is a freelance life sciences and health writer and project manager who has worked with medical extended reality (XR) companies, fiction/nonfiction authors, nonprofit and for-profit organisations and government entities.

StartUp Health Investments

129 Investments

StartUp Health has made 129 investments. Their latest investment was in hav. as part of their Seed VC on June 6, 2022.

CBI Logo

StartUp Health Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/28/2022

Seed VC

hav.

$0.4M

Yes

1

4/13/2022

Series A

9am.health

$16M

Yes

4

2/17/2022

Seed VC

Nexstride

$2.8M

Yes

2

12/14/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

11/4/2021

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/28/2022

4/13/2022

2/17/2022

12/14/2021

11/4/2021

Round

Seed VC

Series A

Seed VC

Series B

Series A - III

Company

hav.

9am.health

Nexstride

Subscribe to see more

Subscribe to see more

Amount

$0.4M

$16M

$2.8M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

4

2

10

10

StartUp Health Portfolio Exits

11 Portfolio Exits

StartUp Health has 11 portfolio exits. Their latest portfolio exit was Vivor on November 29, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/29/2021

Acquired

$99M

1

7/28/2021

Acquired

$99M

4

11/4/2020

Acquired

$99M

1

10/29/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/23/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/29/2021

7/28/2021

11/4/2020

10/29/2020

9/23/2019

Exit

Acquired

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

4

1

10

10

StartUp Health Fund History

2 Fund Histories

StartUp Health has 2 funds, including StartUp Health Transformer Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/30/2017

StartUp Health Transformer Fund II

Accelerator

Closed

$19.3M

2

11/1/2014

StartUp Health Innovation Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

10/30/2017

11/1/2014

Fund

StartUp Health Transformer Fund II

StartUp Health Innovation Fund

Fund Type

Accelerator

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$19.3M

$99M

Sources

2

10

StartUp Health Partners & Customers

10 Partners and customers

StartUp Health has 10 strategic partners and customers. StartUp Health recently partnered with MindTrace on November 11, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

11/29/2021

Partner

United States

3/1/2021

Partner

United States

5/23/2018

Vendor

Finland

Meet us at HIMSS x Health 2.0 Europe 2018! Written by Valeriya Kushchuk | May 23, 2018 12:50:24 PM.

StartUp Health selected Buddy Healthcare to join the movement as one of the first five Finnish companies in 2016 .

1

3/15/2018

Partner

United States

Subscribe to see more

Subscribe to see more

0

1/12/2017

Partner

Germany

Subscribe to see more

Subscribe to see more

10

Date

11/29/2021

3/1/2021

5/23/2018

3/15/2018

1/12/2017

Type

Partner

Partner

Vendor

Partner

Partner

Business Partner

Country

United States

United States

Finland

United States

Germany

News Snippet

Meet us at HIMSS x Health 2.0 Europe 2018! Written by Valeriya Kushchuk | May 23, 2018 12:50:24 PM.

StartUp Health selected Buddy Healthcare to join the movement as one of the first five Finnish companies in 2016 .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

0

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.